一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Biochemical Engineering>Inhibitors>Neuronal Signaling>AChR antagonist>Darifenacin hydrobromide
Darifenacin hydrobromide
  • Darifenacin hydrobromide

Darifenacin hydrobromide NEW

Price $42 $50
Package 50mg 100mg
Supply Ability: 10g
Update Time: 2026-06-02

Product Details

Product Name: Darifenacin hydrobromide CAS No.: 133099-07-7
Purity: 99.75% Supply Ability: 10g
Release date: 2026/06/02

Product Introduction

Bioactivity

NameDarifenacin hydrobromide
DescriptionDarifenacin hydrobromide (UK-88525) is a selective muscarinic receptor antagonist used to treat urinary incontinence and overactive bladder syndrome.
In vitroDarifenacin exerts non-parallel rightward displacement of the agonist curve and also significant depression of the maximum response (+)-cis-Dioxolane produced concentration-dependent contraction of the isolated bladder of rat. [1] Darifenacin produces a concentration dependent increase in R123 (P-gp probe) accumulation in MDCK cells. Darifenacin stimulates ATPase activity in P-gp membrane in a clear concentration dependent response manner with an estimated ED50 value of 1.6?μM. Darifenacin (100 nM) shows a significantly greater permeability for darifenacin in the basolateral to apical direction resulting in an efflux ratio in BBMEC monolayers of approximately 2.6. [2]
In vivoDarifenacin produces dose-dependent inhibition of amplitude of volume-induced bladder contractions(VIBCAMP), producing 35% inhibition at dose of 283.3 nmol/kg and maximal inhibition of approximately 50–55%. [1] Darifenacin (0.1 mg/kg i.v.) reduces bladder afferent activity in both Aδ and C fibers in female Sprague-Dawley rats, the decrease in afferent spikes in C fibers may be more pronounced than that in Aδ fibers. [3] Darifenacin (7.5 mg and 15 mg, daily) reduces the number of incontinence episodes per week from baseline by 67.7% and 72.8% respectively compared with 55.9% with placebo in patients with overactive bladder (OAB). Darifenacin (7.5 mg and 15 mg, daily) also shows significantly superior to placebo for improvements in micturition frequency, bladder capacity, frequency of urgency, severity of urgency and number of incontinence episodes leading to a change in clothing or pads in patients with overactive bladder (OAB). [4]
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility Information10% DMSO+90% Saline : 7.14 mg/mL (14.13 mM), Solution.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 3.3 mg/mL (6.53 mM), Sonication is recommended.
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 71.43 mg/mL (141.32 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
KeywordsUK88525 | UK 88525 | Muscarinic acetylcholine receptor | mAChR | M3 mAChR | Inhibitor | inhibit | Darifenacin hydrobromide | Darifenacin
Inhibitors RelatedAceglutamide | Hyaluronic acid | Urethane | Fumaric acid | Adenine | Ethyl linoleate | D-Psicose | Mitotane | Methyl eugenol | N,N-Dicyclohexylcarbodiimide | Arecoline | 2,3-Butanediol
Related Compound LibrariesFailed Clinical Trials Compound Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | FDA-Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | Anti-Cancer Drug Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
VIP6Y
WUHAN FORTUNA CHEMICAL CO., LTD
2026-07-08
$120.00
Henan Bao Enluo International TradeCo.,LTD
2023-08-12
$210.00
Baoji Guokang Healthchem co.,ltd
2021-11-02
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-13
$1.00
VIP8Y
Career Henan Chemical Co
2019-07-06
$15.00
Zhuozhou Wenxi import and Export Co., Ltd
2021-07-09

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY
和龙市| 呈贡县| 高雄市| 渝中区| 巴里| 五指山市| 德保县| 丹棱县| 蒙山县| 浦江县| 桂平市| 溆浦县| 苏尼特左旗| 武平县| 深泽县| 团风县| 通许县| 元阳县| 凤山市| 扶绥县| 皮山县| 南通市| 林州市| 宝鸡市| 诸暨市| 台东市| 裕民县| 都昌县| 宜城市| 光泽县| 乐安县| 忻城县| 靖江市| 天长市| 鹤庆县| 安多县| 红安县| 左权县| 洛川县| 翁牛特旗| 徐汇区|